Free tool
Dividend paying stocks
We cover 35 companies that currently pay a dividend. The median market value in the group is $2.69B. Across the group, the median move over the past trading day is +0.35%. 50% of the 34 with a 200-day average trade above it. Price change over the past year runs from −26.3% to +26.8% across the middle 80 percent of the group, with a median of −7.2%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
35 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| KRK.WA | Krka, d. d. | $9.20B | Mid cap | +30.59% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% |
| ALK-B.CO | ALK-Abelló A/S | $7.26B | Mid cap | +5.09% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +8.99% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% |
| CTEC.L | Convatec Group PLC | $6.01B | Mid cap | −1.95% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.61B | Mid cap | −9.62% |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +0.68% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | −8.20% |
| FIE.DE | Fielmann Group AG | $3.79B | Mid cap | −27.31% |
| VIRP.PA | Virbac SA | $3.24B | Mid cap | −2.08% |
| AFX.DE | Carl Zeiss Meditec AG | $3.19B | Mid cap | −24.83% |
| BIOA-B.ST | BioArctic AB (publ) | $3.00B | Mid cap | +12.31% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $2.99B | Mid cap | −24.65% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +27.27% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% |
| VISTN.OL | Vistin Pharma ASA | $91.60M | Micro cap | −15.42% |
| OMDA.OL | Omda AS | $81.21M | Micro cap | −23.98% |
| GENT.OL | Gentian Diagnostics ASA | $65.68M | Micro cap | −30.41% |
| AJ91.DE | DocCheck AG | $64.48M | Micro cap | −9.92% |
| HVO.L | hVIVO plc | $59.87M | Micro cap | −35.00% |
| OHGR.L | One Health Group Plc | $53.82M | Micro cap | +17.03% |
| SVS.MI | Svas Biosana S.p.A. | $50.68M | Micro cap | +0.98% |
| M3V.DE | MeVis Medical Solutions AG | $50.50M | Micro cap | −0.42% |
| ABLD.PA | ABL Diagnostics Société anonyme | $44.99M | Micro cap | −46.67% |
| X74.F | I.M.D. International Medical Devices S.p.A. | $20.60M | Micro cap | −22.17% |
| GME.DE | Geratherm Medical AG | $15.65M | Micro cap | −16.50% |
| PHR.WA | Pharmena S.A. | $9.45M | Micro cap | −8.72% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.